SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (1340)10/28/1998 12:45:00 PM
From: Joe E.  Read Replies (1) of 2135
 
I couldn't read the article either, but it seems to me that one of the claims in one of the press releases that I did read said that the compound CM101 "protected" nerve cells in culture, whatever that means. Perhaps this makes it unique in some way among the many antiangiogenesis drugs out there. But probably, this morning, some mice are being sacrificed to test Thalidomide and AG3340 and other agents to see what effect they have on spinal cord injuries. A search for CM101 indicates that it is in Phase 1 clinical testing for cancer in humans, and seems safe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext